| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2016) |
Kenta Teruya [Japon] ; Yasunao Hattori [Japon] ; Yasuhiro Shimamoto [Japon] ; Kazuya Kobayashi [Japon] ; Akira Sanjoh [Japon] ; Atsushi Nakagawa [Japon] ; Eiki Yamashita [Japon] ; Kenichi Akaji [Japon] | Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza‐decaline scaffold |
| 000028 (2016) |
Lanjun Zhang [République populaire de Chine] ; Guolong Huang [République populaire de Chine] ; Qixu Cai [République populaire de Chine] ; Chen Zhao [République populaire de Chine] ; Liuyun Tang [République populaire de Chine] ; Haixia Ren [République populaire de Chine] ; Peng Li [République populaire de Chine] ; Ning Li [République populaire de Chine] ; Jianwei Huang [République populaire de Chine] ; Xueqin Chen [République populaire de Chine] ; Yi Guan [République populaire de Chine] ; Han You [République populaire de Chine] ; Shuhui Chen [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Tianwei Lin [République populaire de Chine] | Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71 |
| 000033 (2016) |
Yoshio Hamada [Japon] ; Yoshiaki Kiso [Japon] | New directions for protease inhibitors directed drug discovery |
| 000123 (2015) |
Jingjing Gao [République populaire de Chine] ; Xianjin Luo [République populaire de Chine] ; Yuhuan Li [République populaire de Chine] ; Rongmei Gao [République populaire de Chine] ; Haifeng Chen [République populaire de Chine] ; Dingjue Ji [République populaire de Chine] | Synthesis and Biological Evaluation of 2‐oxo‐pyrazine‐3‐carboxamide‐yl Nucleoside Analogues and Their Epimers as Inhibitors of Influenza A Viruses |
| 000144 (2015) |
| PRECISION MEDICINE 2015: FROM PSYCHOTROPIC MEDICATION TO PROTON PUMP INHIBITORS |
| 000239 (2014) |
Mafalda Pagano [Italie] ; Daniele Castagnolo [Italie] ; Martina Bernardini [Italie] ; Anna Lucia Fallacara [Italie] ; Ilaria Laurenzana [Italie] ; Davide Deodato [Italie] ; Ulrich Kessler [Suisse] ; Beatrice Pilger [Suisse] ; Lilli Stergiou [Suisse] ; Stephan Strunze [Suisse] ; Cristina Tintori [Italie] ; Maurizio Botta [Italie, États-Unis] | The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors |
| 000523 (2012) |
Akbar Ali [États-Unis] ; Jinhua Wang [États-Unis] ; Robin S. Nathans [États-Unis] ; Hong Cao [États-Unis] ; Natalia Sharova [États-Unis] ; Mario Stevenson [États-Unis] ; Tariq M. Rana [États-Unis] | Synthesis and Structure–Activity Relationship Studies of HIV‐1 Virion Infectivity Factor (Vif) Inhibitors that Block Viral Replication |
| 000574 (2012) |
Jerica Saboti [Slovénie] ; Janko Kos [Slovénie] | Microbial and fungal protease inhibitors—current and potential applications |
| 000966 (2010) |
O. B. Kazakova [Russie] ; N. I. Medvedeva [Russie] ; I. P. Baikova [Russie] ; G. A. Tolstikov [Russie] ; T. V. Lopatina [Russie] ; M. S. Yunusov [Russie] ; L. Zaprutko [Pologne] | Synthesis of triterpenoid acylates: Effective reproduction inhibitors of influenza A (H1N1) and papilloma viruses |
| 001043 (2008) |
William E. Severson ; Michael Mcdowell ; Subramaniam Ananthan [États-Unis] ; Dong-Hoon Chung ; Lynn Rasmussen ; Melinda I. Sosa ; E. Lucile White ; James Noah ; Colleen B. Jonsson | High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2) |
| 001054 (2008) |
Ling-Hon Matthew Chu [République populaire de Chine] ; Siu-Hong Chan [République populaire de Chine] ; Sau-Na Tsai [République populaire de Chine] ; Yi Wang [République populaire de Chine] ; Christopher Hon-Ki Cheng [République populaire de Chine] ; Kam-Bo Wong [République populaire de Chine] ; Mary Miu-Yee Waye [République populaire de Chine] ; Sai-Ming Ngai [République populaire de Chine, Hong Kong] | Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS‐CoV): In search of potent SARS‐CoV entry inhibitors |
| 001074 (2008) |
Usman Bacha [États-Unis] ; Jennifer Barrila [États-Unis] ; Sandra B. Gabelli [États-Unis] ; Yoshiaki Kiso [Japon] ; L. Mario Amzel [États-Unis] ; Ernesto Freire [États-Unis] | Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro |
| 001319 (2007) |
Dariusz Plewczynski [Pologne] ; Marcin Hoffmann [Pologne] ; Marcin Von Grotthuss [Pologne] ; Krzysztof Ginalski [Pologne] ; Leszek Rychewski [Pologne] | In Silico Prediction of SARS Protease Inhibitors by Virtual High Throughput Screening |
| 001378 (2007) |
William E. Severson [États-Unis] ; Nice Shindo ; Mindy Sosa [États-Unis] ; Thomas Fletcher [États-Unis] ; E. Lucile White [États-Unis] ; Subramaniam Ananthan [États-Unis] ; Colleen B. Jonsson [États-Unis] | Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library |
| 001565 (2006) |
Marcin Hoffmann [Pologne] ; Krystian Eitner [Pologne] ; Marcin Von Grotthuss [Pologne] ; Leszek Rychlewski [Pologne] ; Ewa Banachowicz [Pologne] ; Tomasz Grabarkiewicz [Pologne] ; Tomasz Szkoda [Pologne] ; Andrzej Kolinski [Pologne] | Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors |
| 001724 (2006) |
Lili Chen [République populaire de Chine] ; Shuai Chen [République populaire de Chine] ; Chunshan Gui [République populaire de Chine] ; Jianhua Shen [République populaire de Chine] ; Xu Shen [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] | Discovering Severe Acute Respiratory Syndrome Coronavirus 3CL Protease Inhibitors: Virtual Screening, Surface Plasmon Resonance, and Fluorescence Resonance Energy Transfer Assays |
| 001789 (2006) |
Samer I. Al-Gharabli [Jordanie] ; Syed T. Ali Shah ; Steffen Weik ; Marco F. Schmidt [Allemagne] ; Jeroen R. Mesters [Allemagne] ; Daniel Kuhn [Allemagne] ; Gerhard Klebe [Allemagne] ; Rolf Hilgenfeld [Allemagne] ; Jörg Rademann [Allemagne] | An Efficient Method for the Synthesis of Peptide Aldehyde Libraries Employed in the Discovery of Reversible SARS Coronavirus Main Protease (SARS‐CoV Mpro) Inhibitors |
| 001955 (2005) |
Bing Liu [République populaire de Chine] ; Jiaju Zhou [République populaire de Chine] | SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries |
| 001D76 (2004) |
Shin-Ru Shih [République populaire de Chine] ; Shu-Jen Chen [République populaire de Chine] ; Gholam Hossein Hakimelahi [République populaire de Chine] ; Hsing-Jang Liu [République populaire de Chine] ; Chen-Tso Tseng [République populaire de Chine] ; Kak-Shan Shia [République populaire de Chine, Taïwan] | Selective human enterovirus and rhinovirus inhibitors: An overview of capsid‐binding and protease‐inhibiting molecules |
| 001F11 (2004) |
Julia Magden [Finlande] ; Leevi K Ri Inen [Finlande] ; Tero Ahola [Finlande] | Inhibitors of virus replication: recent developments and prospects |
| 002416 (1996) |
Nicholas A. Meanwell [États-Unis] ; Mark Krystal [États-Unis] | Taking aim at a moving target — inhibitors of influenza virus Part 2: viral replication, packaging and release |
